Latest Insider Transactions at Kala Pharmaceuticals, Inc. (KALA)
This section provides a real-time view of insider transactions for Kala Pharmaceuticals, Inc. (KALA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kala Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kala Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2023
|
Marjan Farid |
BUY
Grant, award, or other acquisition
|
Direct |
1,600
+50.0%
|
-
|
|
May 31
2023
|
Howard B Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
2,502
+42.4%
|
-
|
|
Mar 10
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Indirect |
66,131
+28.03%
|
-
|
|
Mar 10
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
2,013
+28.04%
|
-
|
|
Mar 10
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,977
+23.74%
|
-
|
|
Feb 15
2023
|
Mark S. Blumenkranz |
SELL
Other acquisition or disposition
|
Indirect |
70
-0.16%
|
-
|
|
Feb 15
2023
|
Mark S. Blumenkranz |
SELL
Other acquisition or disposition
|
Direct |
3
-0.1%
|
-
|
|
Jan 04
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
198
-0.43%
|
$5,544
$28.54 P/Share
|
|
Jan 04
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
41,700
+47.46%
|
-
|
|
Jan 04
2023
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
62
-0.42%
|
$1,736
$28.54 P/Share
|
|
Jan 04
2023
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+46.21%
|
-
|
|
Jan 04
2023
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
73
-0.39%
|
$2,044
$28.53 P/Share
|
|
Jan 04
2023
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+40.75%
|
-
|
|
Jan 04
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
60
-0.5%
|
$1,680
$28.54 P/Share
|
|
Jan 04
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,525
+44.37%
|
-
|
|
Jan 04
2023
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
60
-0.52%
|
$1,680
$28.55 P/Share
|
|
Jan 04
2023
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
9,525
+45.19%
|
-
|
|
Jan 04
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,525
+38.15%
|
-
|
|
Oct 26
2022
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
561
-11.16%
|
$3,366
$6.52 P/Share
|
|
Oct 26
2022
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
261
-4.3%
|
$1,566
$6.51 P/Share
|
|
Oct 26
2022
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
194
-7.43%
|
$1,164
$6.51 P/Share
|
|
Oct 26
2022
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
214
-9.26%
|
$1,284
$6.51 P/Share
|
|
Oct 26
2022
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
194
-8.72%
|
$1,164
$6.52 P/Share
|
|
Jun 27
2022
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,975
-3.08%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
3,092
-2.61%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
3,144
-1.09%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,613
-1.96%
|
$0
$0.37 P/Share
|
|
Jun 27
2022
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
2,613
-2.3%
|
$0
$0.37 P/Share
|
|
May 26
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,005,686
-12.5%
|
$0
$0.36 P/Share
|
|
May 25
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,434,509
-15.13%
|
$0
$0.42 P/Share
|
|
May 24
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
144,805
-1.5%
|
$0
$0.51 P/Share
|
|
May 23
2022
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,250,000
-11.49%
|
$0
$0.65 P/Share
|
|
Feb 15
2022
|
Darius Kharabi CHIEF BUSINESS OFFICER |
SELL
Other acquisition or disposition
|
Direct |
9
-0.06%
|
-
|
|
Jan 04
2022
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
2,850
-2.44%
|
$2,850
$1.3 P/Share
|
|
Jan 04
2022
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
9,518
-3.54%
|
$9,518
$1.3 P/Share
|
|
Jan 04
2022
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
3,454
-2.83%
|
$3,454
$1.3 P/Share
|
|
Jan 04
2022
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
3,504
-1.2%
|
$3,504
$1.3 P/Share
|
|
Jan 04
2022
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,850
-2.09%
|
$2,850
$1.3 P/Share
|
|
Nov 15
2021
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Indirect |
5,183,355
+50.0%
|
-
|
|
Nov 15
2021
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
157,765
+50.0%
|
-
|
|
Nov 15
2021
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
295,657
+50.0%
|
-
|
|
Oct 27
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
21,051
-9.33%
|
$21,051
$1.82 P/Share
|
|
Oct 26
2021
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
27,598
-9.32%
|
$27,598
$1.8 P/Share
|
|
Oct 26
2021
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
12,757
-4.19%
|
$12,757
$1.8 P/Share
|
|
Oct 26
2021
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
12,544
-9.32%
|
$12,544
$1.8 P/Share
|
|
Oct 26
2021
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,449
-6.49%
|
$9,449
$1.8 P/Share
|
|
Oct 26
2021
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
9,449
-7.49%
|
$9,449
$1.8 P/Share
|
|
Oct 26
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
9,449
-4.02%
|
$9,449
$1.8 P/Share
|
|
Jun 29
2021
|
Hongming Chen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,548
-2.31%
|
$27,740
$5.56 P/Share
|
|
Jun 28
2021
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,586
-2.5%
|
$37,930
$5.77 P/Share
|